What is NDC 51655-143?

51655-143 is the product NDC for Gemfibrozil, Gemfibrozil 600 mg/1 tablet, listed with the FDA by Northwind Health Company, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gemfibrozil?

42 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gemfibrozil NDC 51655-143 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51655-143Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51655-0143Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51655-143-25	5165501432551655014325	60 TABLET in 1 BOTTLE, PLASTIC (51655-143-25)Marketed from Dec 6, 2022
51655-143-26	5165501432651655014326	90 TABLET in 1 BOTTLE, PLASTIC (51655-143-26)Marketed from Aug 14, 2017
51655-143-52	5165501435251655014352	30 TABLET in 1 BOTTLE, PLASTIC (51655-143-52)Marketed from Nov 13, 2017
51655-143-83	5165501438351655014383	180 TABLET in 1 BOTTLE, PLASTIC (51655-143-83)Marketed from Aug 14, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gemfibrozil
Generic name (nonproprietary): gemfibrozil
Active ingredients: Gemfibrozil — 600 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Northwind Health Company, LLCNDC labeler code 51655
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077836
Marketing start: Aug 14, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Fibric Acids (Chemical structure)Peroxisome Proliferator-activated Receptor alpha Agonists (Mechanism)
Identifiers: Product ID 51655-143_48c3ec58-2075-5cc3-e063-6394a90aaffaSPL ID 48c3ec58-2075-5cc3-e063-6394a90aaffaSPL set ID a95264ab-eb86-7699-e053-2995a90a3d1fRxCUI 310459UNII Q8X02027X3
Pharmacologic class: Peroxisome Proliferator Receptor alpha Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655014325 followed by a unit qualifier and the quantity

Package 51655-0143-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Gemfibrozil Tablets are indicated as adjunctive therapy to diet for: 1. Treatment of adult patients with very high elevations of serum triglyceride levels (Types IV and V hyperlipidemia) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. Patients who present such risk typically have serum triglycerides over 2,000 mg/dL and have elevations of VLDL-cholesterol as well as fasting chylomicrons (Type V hyperlipidemia). Subjects who consistently have total serum or plasma triglycerides below 1,000 mg/dL are unlikely to present a risk of pancreatitis. Gemfibrozil therapy may be considered for those subjects with…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51655-143

What is NDC 51655-143?: 51655-143 is the product NDC for Gemfibrozil, Gemfibrozil 600 mg/1 tablet, listed with the FDA by Northwind Health Company, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gemfibrozil.
What is the active ingredient?: Gemfibrozil.
Who is the labeler?: Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gemfibrozil?: 42 other product NDCs are listed under this name. See all Gemfibrozil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gemfibrozil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gemfibrozil	Gemfibrozil 600 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4764	70518-4764-00
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Coupler LLC	67046-0233	67046-0233-03
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	REMEDYREPACK INC.	70518-4305	70518-4305-00
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Preferred Pharmaceuticals, Inc.	68788-7964	68788-7964-0368788-7964-0668788-7964-09
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-128	31722-0128-0531722-0128-60
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	A-S Medication Solutions	50090-5808	50090-5808-0050090-5808-0250090-5808-03+1 more
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	A-S Medication Solutions	50090-7809	50090-7809-00
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2387	68071-2387-0368071-2387-0668071-2387-08
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Bryant Ranch Prepack	71335-1996	71335-1996-0171335-1996-0271335-1996-03+2 more
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-601	71610-0601-5371610-0601-60

All 43 Gemfibrozil NDCs

Other NDCs under ANDA 077836

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077836
Product	Strength	Form · route	Labeler	Product NDC
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-745
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	AvPAK	50268-350
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	American Health Packaging	60687-224
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Proficient Rx LP	63187-772
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	66267-436
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Coupler LLC	67046-0233
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-1733
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Cipla USA Inc.	69097-821
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	REMEDYREPACK INC.	70518-1563
Gemfibrozil	Gemfibrozil 600 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-107
Gemfibrozil	Gemfibrozil 600 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-200
Gemfibrozil	Gemfibrozil 600 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals, Inc.	76282-225